Anti-PD-1 antibody (unspecified)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Anti-PD-1 antibody (unspecified), covering 2024-08-21 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Test Different Doses of BI 1831169 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors) [Phase 1]